Results 181 to 190 of about 113,903 (250)

Observations on an Open‐Label Phase 1/2 Dopamine Gene Therapy Trial (OXB‐102/Axo‐Lenti‐PD) in People with Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background SUNRISE‐PD was a dose‐escalating, phase 1/2 study investigating a second‐generation lentiviral vector gene therapy delivering the genes for dopamine synthesis (OXB‐102) to treat Parkinson's disease (PD). The trial was prematurely terminated due to insolvency of the sponsor.
Simon Rowe   +19 more
wiley   +1 more source

Diurnal‐Only Foslevodopa/Foscarbidopa

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Alexandra McGuckin   +3 more
wiley   +1 more source

Early Remission of Cerebrospinal Fluid Interleukin‐6 After Initial Immunotherapy Predicts a Good Prognosis in Autoimmune Encephalitis

open access: yesNeurology and Clinical Neuroscience, EarlyView.
ABSTRACT Background Autoimmune encephalitis therapy requires adjusting the regimen based on therapeutic response; however, clinical indicators of this response remain unknown. Aim To determine the predictive capability of cerebrospinal fluid (CSF), electroencephalography (EEG), and brain magnetic resonance imaging (MRI) in identifying responders to ...
Yuta Madokoro   +8 more
wiley   +1 more source

Weight Change Between Pregnancies and Mortality Over 50 Years of Follow‐Up

open access: yesObesity, EarlyView.
ABSTRACT Objective This study aimed to evaluate the link between postpartum weight retention (PPWR) and long‐term mortality. Methods In this secondary analysis of 8165 women with ≥ 2 pregnancies in the Collaborative Perinatal Project (CPP), U.S., 1959–1966, with vital status follow‐up through 2016, we used interconception weight change (ICWC) and ...
Yajnaseni Chakraborti   +10 more
wiley   +1 more source

Early Cervical and Orofacial Variable Dystonia in Levodopa‐Naïve PRKN Parkinson's Disease

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Amy Gallagher   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy